Xpert CT/NG regulatory update

Cepheid received CE Mark approval for its Xpert CT/NG test to detect and differentiate Chlamydia trachomatis and Neisseria gonorrhoeae. Cepheid plans to immediately launch the rapid in vitro molecular...